Poulvac E. coli
Poulvac E. coli lyophilisate for suspension for spray vaccination for chickens and turkeys or for use in drinking water for chickens
Table of contents
Overview
This is a summary of the European Public Assessment Report (EPAR) for Poulvac E. coli. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use.
For practical information about using Poulvac E. coli animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Poulvac E. coli
|
Agency product number |
EMEA/V/C/002007
|
Active substance |
Live aroA gene deleted Escherichia coli, type 078, strain EC34195
|
International non-proprietary name (INN) or common name |
Poulvac E. coli lyophilisate for suspension for spray vaccination for chickens and turkeys or for use in drinking water for chickens
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AE04
|
Publication details | |
---|---|
Marketing-authorisation holder |
Zoetis Belgium SA
|
Revision |
9
|
Date of issue of marketing authorisation valid throughout the European Union |
15/06/2012
|
Contact address |
Product information
21/08/2020 Poulvac E. coli - EMEA/V/C/002007 - IB/0017
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
-
Immunologicals for aves
-
Live bacterial vaccines
Therapeutic indication
For active immunisation of broiler chickens and future layers / breeders in order to reduce mortality and lesions (pericarditis, perihepatitis, airsacculitis) associated with Escherichia coli serotype O78.